Clinical Value of Serum Uric Acid in Patients with Suspected Coronary Artery Disease
2
조회
0
다운로드
1
인용
0
참고문헌
초록
Background/Aims: Although increased serum uric acid (SUA) concentrations are commonly encountered in patients with risk factors for coronary artery disease (CAD), the clinical value of SUA has not been established. Methods: The study group comprised 687 consecutive patients with suspected CAD who had undergone coronary angiography. CAD was defined as stenosis ≥ 50% of the luminal diameter. CAD severity was expressed as 1-, 2-, or 3-vessel disease. Metabolic syndrome (MS) was defined according to National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) criteria, and aortofemoral pulse wave velocity (PWV) was obtained by arterial catheterization invasively. Results: In total, 395 patients had CAD. SUA was higher in patients with CAD as compared to those without CAD (5.5 ± 1.0 vs. 5.2 ± 1.0 mg/dL, p = 0.004). In addition, SUA was significantly associated with the severity of CAD (p = 0.002). However, after adjusting for significant confounding factors including age, diabetes, smoking, cholesterol, MS, and PWV, SUA was not an independent risk factor for CAD (p = 0.151). Based on a subgroup analysis, SUA was more closely associated with CAD in women than in men, and in the highest quartile (≥ 6.4 mg/dL) than in the first quartile (< 4.8 mg/dL); however, these results were not significant (p = 0.062, p = 0.075,respectively). In a multivariate regression analysis, the most important determinant of SUA was MS (i.e., insulin resistance syndrome), which is strongly associated with CAD. Conclusions: In patients with suspected CAD, SUA was not an independent risk factor for CAD and may be merely a marker of insulin resistance. (Korean J Intern Med 2010;25:21-26)
Abstract
Background/Aims: Although increased serum uric acid (SUA) concentrations are commonly encountered in patients with risk factors for coronary artery disease (CAD), the clinical value of SUA has not been established. Methods: The study group comprised 687 consecutive patients with suspected CAD who had undergone coronary angiography. CAD was defined as stenosis ≥ 50% of the luminal diameter. CAD severity was expressed as 1-, 2-, or 3-vessel disease. Metabolic syndrome (MS) was defined according to National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) criteria, and aortofemoral pulse wave velocity (PWV) was obtained by arterial catheterization invasively. Results: In total, 395 patients had CAD. SUA was higher in patients with CAD as compared to those without CAD (5.5 ± 1.0 vs. 5.2 ± 1.0 mg/dL, p = 0.004). In addition, SUA was significantly associated with the severity of CAD (p = 0.002). However, after adjusting for significant confounding factors including age, diabetes, smoking, cholesterol, MS, and PWV, SUA was not an independent risk factor for CAD (p = 0.151). Based on a subgroup analysis, SUA was more closely associated with CAD in women than in men, and in the highest quartile (≥ 6.4 mg/dL) than in the first quartile (< 4.8 mg/dL); however, these results were not significant (p = 0.062, p = 0.075,respectively). In a multivariate regression analysis, the most important determinant of SUA was MS (i.e., insulin resistance syndrome), which is strongly associated with CAD. Conclusions: In patients with suspected CAD, SUA was not an independent risk factor for CAD and may be merely a marker of insulin resistance. (Korean J Intern Med 2010;25:21-26)
참고문헌 (20)
- Lee J, "Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome: the Normative Aging Study", Am J Epidemiol, 142, pp.288~294 (1995)
- Frohlich ED, "Uric acid: a risk factor for coronary heart disease", JAMA, 270, pp.378~379 (1993)
- Puig JG, "Female gout: clinical spectrum and uric acid metabolism", Arch Intern Med, 151, pp.726~732 (1991)
- Puig JG, "Uric acid as a cardiovascular risk factor in arterial hypertension", J Hypertens, 17, pp.869~872 (1999)
- Franse LV, "Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP)", J Hypertens, 18, pp.1149~1154 (2000)
- Verdecchia P, "Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA Study", Hypertension, 36, pp.1072~1078 (2000)
- Fang J, "Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992: National Health and Nutrition Examination Survey", JAMA, 283, pp.2404~2410 (2000)
- Culleton BF, "Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study", Ann Intern Med, 131, pp.7~13 (1999)
- Levine W, "Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry", J Clin Epidemiol, 42, pp.257~267 (1989)
- Cappuccio FP, "Uric acid metabolism and tubular sodium handling: results from a population-based study", JAMA, 270, pp.354~359 (1993)
- National Cholesterol Education Program (NCEP), "Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program", JAMA, 285, pp.2486~2497 (2001)
- Freedman DS, "Relation of serum uric acid to mortality and ischemic heart disease: the NHANES I Epidemiologic Follow-up Study", Am J Epidemiol, 141, pp.637~644 (1995)
- Alderman MH, "Increased serum uric acid associated with increased cardiovascular disease in treated hypertensive patients", J Hypertens, 16, pp.S5~ (1998)
- Ward HJ, "Uric acid as an independent risk factor in the treatment of hypertension", Lancet, 352, pp.670~671 (1998)
- Emmerson BT, "Atherosclerosis and urate metabolism", Aust N Z J Med, 9, pp.451~454 (1979)
- Vasquez-Vivar J, "Peroxynitrite-mediated formation of free radicals in human plasma: EPR detection of ascorbyl, albumin-thiyl and uric acidderived free radicals", Biochem J, 314, pp.869~876 (1996)
- Anker SD, "Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure", Heart, 78, pp.39~43 (1997)
- Alberti KG, "Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation", Diabet Med, 15, pp.539~553 (1998)
- Reaven GM, "Syndrome X: 6 years later", J Intern Med Suppl, 736, pp.13~22 (1994)
- Ford ES, "Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey", JAMA, 287, pp.356~359 (2002)